RSS-Feed abonnieren
DOI: 10.1055/s-2006-924701
© Georg Thieme Verlag KG Stuttgart · New York
Secondary Endovascular Repair of a Reconstructed Superior Vena Cava in a Patient with a Malignant Thymic Epithelial Neoplasm
Publikationsverlauf
Received July 21, 2006
Publikationsdatum:
04. Juni 2007 (online)
Introduction
Thymic neoplasms account for approximately 50 % of anterior mediastinal masses. The vast majority of thymomas are cytologically bland neoplasms that exhibit an indolent clinical course [[1]]. Aggressive tumors can cause venous obstruction from extrinsic compression or direct invasion of the superior vena cava (SVC) or the innominate veins (IV s), exhibiting a malignant behavior associated with a poor prognosis. Complete resection of even an extensively invasive tumor remains the cornerstone of therapy and is the most critical factor in determining long-term survival [[2]].
We present a case of a young patient with a malignant thymoma that was treated with tumor resection together with SVC reconstruction. A secondary endovascular procedure was required due to early thrombosis of the reconstructed SVC.
References
- 1 Detterbeck F C, Parsons A M. Thymic tumors. Ann Thor Surg. 2004; 77 1860-1869
- 2 Park B J, Bacchetta M, Bains M S. et al . Surgical management of thoracic malignancies invading the heart or great vessels. Ann Thor Surg. 2004; 78 1024-1030
- 3 Shimizu N, Date H, Moriyama S, Ando A, Teramoto S. Reconstruction of the superior vena cava in patients with mediastinal malignancies. Eur J Cardiothor Surg. 1991; 5 575-578
- 4 Chiu C J, Terzis J, MacRae M L. Replacement of superior vena cava with the spiral composite vein graft: a versatile technique. Ann Thor Surg. 1974; 17 555-560
- 5 Alimi Y S, Gloviczki P, Vrtiska T J. et al . Reconstruction of the superior vena cava: benefits of postoperative surveillance and secondary endovascular interventions. J Vasc Surg. 1998; 27 287-301
- 6 Dartevelle P G, Chapelier A R, Pastorino U. et al . Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors. J Thorac Cardiovasc Surg. 1991; 102 259-265
- 7 Kalra M, Gloviczki P, Andrews J C. et al . Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg. 2003; 38 215-223
- 8 Courtheoux P, Alkofer B, Refai M A, Gervais R, Le Rochais J P, Icard P. Stent placement in superior vena cava syndrome. Ann Thor Surg. 2003; 75 158-161
MD, PhD Nicholas Charokopos
Cardiothoracic Surgeon
22, Grigoriou E' St., Panorama,
Thessaloniki 55236
Greece
Fax: + 30 23 10 99 48 71
eMail: charokoposnick@hotmail.com